ReviewTransplantation and cellular therapy2021

State of the CAR-T: Risk of Infections with Chimeric Antigen Receptor T-Cell Therapy and Determinants of SARS-CoV-2 Vaccine Responses.

Juliet Meir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.